BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25359362)

  • 21. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
    Zhang Z; Jia M; Wan D
    Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public-private partnerships to revitalize psychiatric drug discovery.
    Brady LS; Potter WZ
    Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influenza vaccine innovation system and lessons for PDPs.
    Huzair F
    Hum Vaccin Immunother; 2012 Mar; 8(3):407-10. PubMed ID: 22327495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 25. New strategies for innovation in global health: a pharmaceutical industry perspective.
    Witty A
    Health Aff (Millwood); 2011 Jan; 30(1):118-26. PubMed ID: 21209447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Innovative Medicine Initiative (IMI)].
    Bril A; Canet E
    Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perestroika in pharma: evolution or revolution in drug development?
    FitzGerald GA
    Mt Sinai J Med; 2010; 77(4):327-32. PubMed ID: 20687177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future pharmaceutical research: the need to look beyond science.
    Seeger S
    Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug discovery in pharmaceutical industry: productivity challenges and trends.
    Khanna I
    Drug Discov Today; 2012 Oct; 17(19-20):1088-102. PubMed ID: 22627006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public-private partnerships in translational medicine: concepts and practical examples.
    Luijten PR; van Dongen GA; Moonen CT; Storm G; Crommelin DJ
    J Control Release; 2012 Jul; 161(2):416-21. PubMed ID: 22465390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of product development partnerships in advancing the development of drugs for unmet needs.
    Breitstein J; Spigelman M
    Clin Pharmacol Ther; 2013 Jun; 93(6):468-70. PubMed ID: 23689211
    [No Abstract]   [Full Text] [Related]  

  • 32. The production and R&D structure of the Brazilian pharmaceutical industry: the role of public procurement and public drug production.
    Sorte Junior WF
    Glob Public Health; 2012; 7(10):1062-79. PubMed ID: 22950510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public-private relationships in biobanking: a still underestimated key component of open innovation.
    Hofman P; Bréchot C; Zatloukal K; Dagher G; Clément B
    Virchows Arch; 2014 Jan; 464(1):3-9. PubMed ID: 24337181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PCAST report on pharmaceutical innovation: implications for the FDA.
    Woodcock J
    Clin Pharmacol Ther; 2013 Sep; 94(3):297-300. PubMed ID: 23963215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A renaissance in biomedical innovation: global villages raise effective therapies.
    Collyar D; Chaguturu R
    Future Med Chem; 2015; 7(8):971-4. PubMed ID: 26062394
    [No Abstract]   [Full Text] [Related]  

  • 36. A collaborative pipeline.
    Nat Neurosci; 2015 Jan; 18(1):1. PubMed ID: 25547471
    [No Abstract]   [Full Text] [Related]  

  • 37. The Innovative Medicines Initiative: an engine for regulatory science.
    Goldman M; Seigneuret N; Eichler HG
    Nat Rev Drug Discov; 2015 Jan; 14(1):1-2. PubMed ID: 25503331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is pharma running out of brainy ideas?
    Miller G
    Science; 2010 Jul; 329(5991):502-4. PubMed ID: 20671165
    [No Abstract]   [Full Text] [Related]  

  • 39. Public-private partnerships for health: their main targets, their diversity, and their future directions.
    Widdus R
    Bull World Health Organ; 2001; 79(8):713-20. PubMed ID: 11545327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four disruptive strategies for removing drug discovery bottlenecks.
    Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ
    Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.